AC Immune Corp (ACIU) Company Long-Term Loans and Borrowings

Public company logo of AC Immune Inc (ACIU)

AC Immune (ACIU) revenues are based on bringing neurodegeneration therapies to market, specifically drugs targeting Alzheimer's and Parkinson's diseases. The price action of the securities on the GURU.Markets platform, where the indicator stands at 0.00, confirms market interest in the company's research. High growth potential is driven by the global distribution of patented medicines, while technological superiority is solidified by the Supra Antigen platform and contracts with global industry leaders.

ACIU AC Immune: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for AC Immune

- price and consensus price forecast:
Stock Price acimmune.com|ACIU - Price Target Chart
- market capitalization data:
Market Value AC Immune|ACIU - Total Company Value
- book capitalization data:
Net Asset Value per Share AC Immune|ACIU - Book Capitalization|Market Capitalization to Book Value Ratio acimmune.com|ACIU - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio AC Immune|ACIU - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AC Immune Inc|ACIU - Company Aggregate Debts|Debts to Net Assets AC Immune|ACIU - Company Long-Term Debt|Company Current Liabilities AC Immune
General company analysis:acimmune.com (ACIU)
Mass-produced product of AC Immune Inc

AC Immune occupies a high-risk niche in the development of Alzheimer's disease therapies. This indicator measures the aggregate of obligations with a maturity of more than one year, determining financial stability and the level of debt load. By analyzing the company's long-term debt value, an investor assesses the ability of AC Immune to fund clinical trials in the absence of current sales. Given the dependence on research success, this metric becomes a critical marker of the business's solvency.

Competitor analysis for AC Immune

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACADIA Corp (ACAD) - Long-Term Debt|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts vikingtherapeutics.com|Company Long-Term Debts SUPN (Supernus)|Company Long-Term Liabilities Catalyst Pharma CPRX|Company Long-Term Liabilities Denali Therapeutics Inc|Company Long-Term Loans and Borrowings Harmony Corp HRMY|Company Long-Term Debts BHVN (Biohaven Ltd.)|AMLX: Long-Term Debt Volume|TRVI (Trevi Therapeutics, Inc.) - Company Long-Term Debt|PRAX (Praxis Precision Medicines Inc) - Company Long-Term Liabilities|Company Long-Term Debt AVXL|Company Long-Term Liabilities CeriBell EEG (CBLL)|Company Long-Term Liabilities PRTA|Company Long-Term Debts ALEC (alector.com)|ANNX - Company Long-Term Debt|Company Long-Term Indebtedness Omeros Corp OMER|NGNE (Neurogene Corp) - Company Long-Term Debts|VYGR - Long-Term Debt|NMRA: Company Long-Term Debts|scilexholding.com (SCLX) - Company Long-Term Debts|Company Long-Term Debts TVGN|Company Long-Term Liabilities Alpha Cognition Corp|CGTX (Cognition Therapeutics) - Company Long-Term Debts|Long-Term Debt Volume Inhibikase Pharma IKT|Company Long-Term Liabilities SAVA (Cassava Sciences, Inc.)|Assertio Holdings - Company Long-Term Debts|Coya (COYA) - Company Long-Term Debt|VTGN - Company Long-Term Indebtedness|Company Long-Term Debts OVID|Long-Term Debt Acumen Pharmaceuticals, Inc|CRVO (CervoMed Inc.) - Company Long-Term Liabilities|Company Long-Term Debts ATHE|Clene Inc. (CLNN) - Company Long-Term Debt|Company Long-Term Loans and Borrowings PEPG (pepgen.com)|JUNS: Company Long-Term Debt|Long-Term Debt Relmada Corp RLMD|Annovis Bio, Inc. - Company Long-Term Debts|GRCE - Company Long-Term Debts|AIFF (Firefly Neuroscience) - Company Long-Term Debts|Company Long-Term Liabilities Klotho Neurosciences|NRSN - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Reviva Pharmaceuticals, Inc.|MTVA (MetaVia Inc) - Company Long-Term Debts|Long-Term Debt Volume NRXS (neuraxis.com)|Helius Medical Technologies - Company Long-Term Debt|Passage Bio Inc. - Company Long-Term Liabilities|NEUP: Company Long-Term Debt|Minerva (NERV) - Company Long-Term Liabilities|ATHA: Company Long-Term Liabilities|ADXN (addextherapeutics.com) - Company Long-Term Debts|Company Long-Term Debt Alzamend Neuro Inc. (ALZN)|Company Long-Term Indebtedness Cyclerion|Protagenic Therapeutics - Company Long-Term Debts|Long-Term Debt pasitheaclinics.com (KTTA)|Company Long-Term Debts CRGT (Cortigent)|Company Long-Term Debts avenuetx.com ATXI|BCLI: Company Long-Term Debts|CARA - Company Long-Term Liabilities|Chromocell Therapeutics Corporation - Company Long-Term Debts|Long-Term Debt Volume Eliem Therapeutics Inc.|ITCI (Intra-Cellular Therapies Inc.) - Company Long-Term Liabilities|Company Long-Term Debts LBPH|Company Long-Term Debt Marinus Pharmaceuticals, Inc. MRNS|Company Long-Term Indebtedness NKGen Biotech Inc (NKGN)|NRBO: Company Long-Term Debts|SAGE - Long-Term Debt|Synaptogenix, Inc. - Company Long-Term Liabilities|TRVN: Company Long-Term Debts|Company Long-Term Debt vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Company Long-Term Loans and Borrowings|Company Long-Term Debt CERE (Cerevel)